1. Summary Information

Country

India

Company Name

UNITED BIOTECH PRIVATE LIMITED

Principal Name 1

Mr. Rajiv  Kumar

Status

Good

Principal Name 2

Mrs. Kavita Gakhar

Registration #

55-084814

Street Address

E-142, Saket, New Delhi – 110017, India

Established Date

31.01.1997

SIC Code

--

Telephone#

91-11-26855082/ 40651100

Business Style 1

Manufacturer

Fax #

91-11-26855082/ 66607096

Business Style 2

--

Homepage

www.unitedbiotechindia.com

Product Name 1

Formulations

# of employees

--

Product Name 2

Injections

Paid up capital

Rs. 45,363,000/-

Product Name 3

--

Shareholders

Directors or relatives of directors 100.00%

Banking

Oriental Bank of Commerce

Public Limited Corp.

NO

Business Period

17 Years

IPO

NO

International Ins.

-

Public Enterprise

NO

Rating

Ba (52)

Related Company

Relation

Country

Company Name

CEO

Note

-

 

 

2. Summary Financial Statement

Balance Sheet as of

31.03.2013

(Unit: Indian Rs.)

Assets

Liabilities

Current Assets

2,362,295,000

Current Liabilities

154,773,000

Inventories

333,625,000

Long-term Liabilities

0,000

Fixed Assets

569,107,000

Other Liabilities

244,629,000

Deferred Assets

0,000

Total Liabilities

399,402,000

Invest& other Assets

172,561,000

Retained Earnings

2,992,823,000

 

 

Net Worth

3,038,186,000

Total Assets

3,437,588,000

Total Liab. & Equity

3,437,588,000

 Total Assets

(Previous Year)

 

 

 

P/L Statement as of

31.03.2013

(Unit: Indian Rs.)

Total Income

1,967,394,000

Net Profit

706,603,000

Total Income(Prev yr)

1,501,917,000

Net Profit(Prev yr)

600,950,000

 

 

MIRA INFORM REPORT

 

 

Report Date :

03.06.2014

 

IDENTIFICATION DETAILS

 

Name :

UNITED BIOTECH PRIVATE LIMITED

 

 

Registered Office :

E-142, Saket, New Delhi – 110017

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

31.01.1997

 

 

Com. Reg. No.:

55-084814

 

 

Capital Investment / Paid-up Capital :

Rs.45.363 Millions

 

 

CIN No.:

[Company Identification No.]

U24239DL1997PTC084814

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

DELU02630F

 

 

PAN No.:

[Permanent Account No.]

AAACU1839L

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Products such as Formulations, Injections etc.

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (52)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 7200000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exist

 

 

Comments :

Subject is an established company having fine track record.

 

Financial position of the company appears to be strong. Over all fundamentals of the company appears to be sound and healthy.

 

Directors are reported to be experienced and respectable businessmen.

 

Trade relations are reported to be fair. Business is active. Payments are reported to be usually correct and as per commitment.

 

The company can be considered for normal business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

US investment bank Goldman Sachs  has upgraded its outlook on Indian markets as it expects positive impact of the election cycle.

 

India’s economy may grow 4.7 % in the current financial year, lower than the official estimate of 4.9 %, Fitch Rating said. The global rating agency expects the economy to pick up in the next two financial years.

 

Global ratings agency Standard & Poor said increasing focus by India Inc on lowering debt is likely to improve their credit profiles.

 

Singapore (1.1 million Indian tourists in 2012), Thailand (one million), the United Arab Emirates ().98 million) and Malaysia ().82 million) emerged as the preferred holidays hotspots for Indians. The total figure is expected to increase to 1.93 million by 2017, according to the latest Eurmonitor international report.

 

There is a $29.34 bn outward foreign direct investment by domestic companies between April and January of 2013/14 which has seen some signs of recovery according to a Care Ratings report.

 

There are 264 number of new companies being set up every day on average during 2014. Most of them are registered in Mumbai. India had 1.38 million registered companies at the end of January, 2014.

 

Twitter like messaging service Weibo Corporation has filed to raise $ 500 million via a US initial public offering. Alibaba, which owns a stake in Weibo is expected to raise about $ 15 billion New York this year in the highest profile Internet IPO since Facebook’s in 2012.

 

Bharti Airtel has raised Rs.2,453.2 crore (350 million Swiss Francs) by selling six-year bonds at a coupon rate of three per cent and maturing in 2020. This is the largest ever bond offering by an Indian company in Swiss Francs. Bharat Petroleum Corporation raised 175 million Swiss Francs by selling five year bonds at 2.98 % coupon rate in February.

 

Indian Oil Corporation plans to invest Rs 7650 crore in setting up a petrochemical complex at its almost complete Paradip refinery in Odhisha in three to four years. The company board is set to consider the setting up of a 700000 tonne per annum polypropylene plant at an estimated cost at Rs.3150 crore.

 

Global chief information officers at gathering in Bangalore in April to meet Indian startups at an event called Tech50 Watchout for Little Eye Labs-Facebook type deals in the making.

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

INFORMATION DECLINED

 

MANAGEMENT NON-COOPERATIVE [91-11-40651100]

 

LOCATIONS

 

Registered Office :

E-142, Saket, New Delhi – 110017, India

Tel. No.:

91-11-26855082/ 40651100

Fax No.:

91-11-26855082/ 66607096

E-Mail :

ubpl@del3.vsnl.net.in

ubpl@del3.vsnl.net.in

accounts@unitedbiotechindia.com

administration@unitedbiotechindia.com

Website :

http://www.unitedbiotechindia.com

 

 

Corporate Office :

FC/B-1 (Extn.), Mohan Co-operative Industrial Estate, Mathura Road, New Delhi – 110044, India

Tel. No.:

91-11-40651100/ 66607095/ 66403098/ 99/ 26940762

Fax No.:

91-11-66607096/ 66607091

E-Mail:

ubpl@vsnl.com

 

 

Factory :

Bagbania, Baddi, Nalagarh Road, District Solan – 174101, Himachal Pradesh, India

Te. No.:

91-1795-236904/ 5/ 6

Fax No.:

91-1795-236604

E-Mail :

plant@unitedbiotechindia.com

 

 

DIRECTORS

 

AS ON 30.09.2013

 

Name :

Mr. Rajiv  Kumar

Designation :

Whole-time Director

Address :

E-142, Saket, Delhi – 110017, India

Date of Birth/Age :

09.04.1963

Qualification :

Bachelor in Pharma

Date of Appointment :

22.04.2008

DIN No.:

00073944

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24239DL1997PTC084814

UNITED BIOTECH PRIVATE LIMITED

Whole-time director

22/04/2008

31/01/1997

Active

NO

2

U24233DL2010PTC199814

SORGEN HEALTHCARE PRIVATE LIMITED

Director

08/03/2010

08/03/2010

Active

NO

3

U24297DL2011PTC227673

UMANO HEALTHCARE PRIVATE LIMITED

Director

21/11/2011

21/11/2011

Active

NO

 

Name :

Mrs. Kavita Gakhar

Designation :

Whole-time Director

Address :

E-142, Saket, Delhi – 110017, India

Date of Birth/Age :

11.10.1970

Qualification :

MA

Date of Appointment :

01.08.2007

DIN No.:

00073976

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24239DL1997PTC084814

UNITED BIOTECH PRIVATE LIMITED

Whole-time director

01/08/2007

01/08/2002

Active

NO

2

U24233DL2010PTC199814

SORGEN HEALTHCARE PRIVATE LIMITED

Director

08/03/2010

08/03/2010

Active

NO

3

U24297DL2011PTC227673

UMANO HEALTHCARE PRIVATE LIMITED

Director

21/11/2011

21/11/2011

Active

NO

 

Name :

Mrs. Kailash Devi

Designation :

Whole-time Director

Address :

E-142, Saket, Delhi – 110017, India

Qualification :

MA

Date of Appointment :

22.04.2008

DIN No.:

00074289

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U27101DL1981PTC012739

SUBHAM UDYOG PRIVATE LIMITED

Director

06/06/2001

06/06/2001

Active

NO

2

U24239DL1997PTC084814

UNITED BIOTECH PRIVATE LIMITED

Whole-time director

22/04/2008

01/05/2002

Active

NO

3

U24231DL2011PTC227688

FELIZ LIFECARE PRIVATE LIMITED

Director

21/11/2011

21/11/2011

Active

NO

 

Name :

Mr. Sanjeev Kumar

Designation :

Whole-time Director

Address :

House No. E-142, Saket Malviya Nagar, Delhi – 110017, India

Date of Birth/Age :

26.09.1966

Qualification :

B. Pharma

Date of Appointment :

02.04.2007

DIN No.:

01691559

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24239DL1997PTC084814

UNITED BIOTECH PRIVATE LIMITED

Whole-time director

02/04/2007

02/04/2007

Active

NO

2

U27101DL1981PTC012739

SUBHAM UDYOG PRIVATE LIMITED

Director

27/03/2008

27/03/2008

Active

NO

3

U24231DL2011PTC227688

FELIZ LIFECARE PRIVATE LIMITED

Director

21/11/2011

21/11/2011

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2013

 

Names of Shareholders

 

No. of Shares

%Of Holding

Rajiv Kumar

59233

13.06

Kailash Devi

59233

13.06

Kavita Gakhar

59234

13.06

Monika Gakhar

59233

13.06

Ashwani Kumar

59233

13.06

Sanjeev Kumar

98233

21.65

Preeti Gakhar

59234

13.06

Total

453633

100.00

 

 

AS ON 30.09.2013

 

Equity Share Break up (Percentage of Total Equity)

 

Category

 

Percentage

Directors or relatives of Directors

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Products such as Formulations, Injections etc.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Divulged

 

 

Bankers :

·         Oriental Bank of Commerce, Hauz Khas Branch, New Delhi, India

·         Standard Chartered Bank

·         ICICI Bank Limited

·         HDFC Bank Limited

 

 

Facilities:

--

 

 

 

Auditors :

 

Name :

VPGS and Company

Chartered Accountants

Address :

3208, II Floor, Mahindra Park, New Delhi-110034, India

Tel. No.:

AAGFA7822G

 

 

Associate:

·         Subham Udyog Private Limited

·         American Hospital

·         Services

·         A R Labs

·         The Pharmacy

 

 

Subsidiaries:

·         Sorgen Healthcare Private Limited

·         Umano Healthcare Private Limited

·         Feliz Lifecare Private Limited

 

 

CAPITAL STRUCTURE

 

AS ON 29.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

500000

Equity Shares

Rs. 100/- each

Rs. 50.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

453633

Equity Shares

Rs. 100/- each

Rs. 45.363 Millions

 

 

 

 

 

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

45.363

45.363

(b) Reserves & Surplus

 

2992.823

2339.292

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

3038.186

2384.655

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.000

0.000

(b) Deferred tax liabilities (Net)

 

2.285

6.857

(c) Other long term liabilities

 

35.345

35.330

(d) long-term provisions

 

14.737

9.354

Total Non-current Liabilities (3)

 

52.367

51.541

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

0.000

0.000

(b) Trade payables

 

104.076

111.780

(c) Other current liabilities

 

15.352

9.015

(d) Short-term provisions

 

227.607

150.401

Total Current Liabilities (4)

 

347.035

271.196

 

 

 

 

TOTAL

 

3437.588

2707.392

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

568.551

578.752

(ii) Intangible Assets

 

0.556

0.383

(iii) Capital work-in-progress

 

0.000

0.000

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

172.561

162.560

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

432.689

318.795

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

1174.357

1060.49

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

333.625

252.582

(c) Trade receivables

 

272.687

205.966

(d) Cash and cash equivalents

 

1450.131

1039.067

(e) Short-term loans and advances

 

31.756

8.138

(f) Other current assets

 

175.032

141.149

Total Current Assets

 

2263.231

1646.902

 

 

 

 

TOTAL

 

3437.588

2707.392

 

 

SOURCES OF FUNDS

 

 

 

31.03.2011

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

45.363

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

1743.614

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

1788.977

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

0.000

2] Unsecured Loans

 

 

0.000

TOTAL BORROWING

 

 

0.000

DEFERRED TAX LIABILITIES

 

 

1.268

 

 

 

 

TOTAL

 

 

1790.245

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

444.144

Capital work-in-progress

 

 

0.000

 

 

 

 

INVESTMENT

 

 

0.000

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
 
218.535

 

Sundry Debtors

 
 
185.510

 

Cash & Bank Balances

 
 
812.299

 

Other Current Assets

 
 
117.976

 

Loans & Advances

 
 
221.188

Total Current Assets

 
 
1555.508

Less : CURRENT LIABILITIES & PROVISIONS

 
 
 

 

Sundry Creditors

 
 
0.000

 

Other Current Liabilities

 
 
105.648

 

Provisions

 
 
103.759

Total Current Liabilities

 
 
209.407

Net Current Assets

 
 
1346.101

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

1790.245

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

TOTAL                                    

1967.394

1501.917

1266.664

 

 

 

 

 

Less

EXPENSES

 

 

 

Differed Revenue Expenditure Written off

 

 

0.221

 

 

Other Expenses

 

 

721.731

 

 

TOTAL                                    

1207.091

868.584

721.952

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

760.303

633.333

544.712

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

0.000

0.000

24.260

 

 

 

 

 

 

PROFIT BEFORE TAX                          

760.303

633.333

520.452

 

 

 

 

 

Less

TAX                                                                 

53.700

32.383

103.602

 

 

 

 

 

 

PROFIT AFTER TAX                            

706.603

600.950

416.850

 

 

 

 

 

Add

TAX Paid U/S 115JB (MAT) Carried Forward

0.000

0.000

0.000

 

 

 

 

 

 

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

2339.292

1743.614

1236.919

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

0.000

0.000

0.000

 

 

Dividend

45.363

4.536

0.000

 

 

Tax on Dividend

7.709

0.736

0.000

 

BALANCE CARRIED TO THE B/S

2992.823

2344.564

1743.614

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

143.899

41.033

21.146

 

TOTAL EARNINGS

143.899

41.033

21.146

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

74.530

43.659

51.095

 

TOTAL IMPORTS

74.530

43.659

51.095

 

 

 

 

 

 

Earnings Per Share (Rs.)

1557.65

1324.75

918.91

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

35.91
40.01
32.90

 

 

 
 
 

Return on Total Assets

(PBT/Total Assets}

(%)

23.29
24.89
26.02

 

 

 
 
 

Return on Investment (ROI)

(PBT/Networth)

 

0.25
0.27
0.29

 

 

 
 
 

Debt Equity Ratio

(Total Debt/Networth)

 

NA
NA
0.00

 

 

 
 
 

Current Ratio

(Current Asset/Current Liability)

 

6.52
6.07
7.43

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

 

31.03.2012

31.03.2013

 

 

Rs. In Millions

Rs. In Millions

Share Capital

 

45.363

45.363

Reserves & Surplus

 

2339.292

2992.823

Net worth

 

2384.655

3038.186

 

 

 

 

long-term borrowings

 

0.000

0.000

Short term borrowings

 

0.000

0.000

Total borrowings

 

0.000

0.000

Debt/Equity ratio

 

0.000

0.000

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

1,266.664

1,501.917

1,967.394

 

 

18.573

30.992

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

1,266.664

1,501.917

1,967.394

Profit

416.850

600.950

706.603

 

32.91%

40.01%

35.92%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report

(Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

---------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

---------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

Yes

24]

Banking facility details

No

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

VIEW INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10167751

21/07/2009

3,000,000.00

DIRECTOR OF INDUSTRIES

THROUGH DEPUTY DIRECTOR OF INDUSTRIES, SINGLE WINDOW CLEARANCE AGENCY, NALAGARH, HIMACHAL PRADESH - 173211, INDIA

A66436221

2

90337196

04/02/2013 *

62,500,000.00

ORIENTAL BANK OF COMMERCE

HAUZ KHAS INSTITUTIONAL AREA, NEW DELHI, DELHI - 110016, INDIA

B69129039

 

 

 

 

 

 

 

 

 

LITIGATION DETAILS:

 

 

CASE PENDING:

 

CS(OS) 2037/2011
    
GLAXO GROUP LTD. ..... Plaintiff
  
Through Mr. Manav Kumar, Advocate

versus

UNITED BIOTECH P. LTD. ..... Defendant
  
Through Mr. Siddhant Goel, Mr.Rahul Sharma and Ms.Sangeeta Goel,  Advocates
  
 CORAM:
  
HON'BLE MR. JUSTICE JAYANT NATH
  
O R D E R
  
08.10.2013
 

IA No. 13265/2011 (u/O 39 R 1 and 2 CPC) and 14230/2011 (u/O 39 R 4 CPC)
  
Arguments heard.
  
Judgment reserved.

JAYANT NATH, J
  
OCTOBER 08, 2013
rb
$ F2A

 

 

FIXED ASSETS:

·         Land

·         Factory Building

·         Plant and Machinery

·         Electrical Installation

·         Furniture and Fixture

·         Vehicles

·         Computers

·         Office Equipment

·         Capital Work in Progress


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 59.14

UK Pound

1

Rs. 99.02

Euro

1

Rs. 80.63

 

 

INFORMATION DETAILS

 

Information Gathered by :

PLK

 

 

Report Prepared by :

NKT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

52

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.